Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 18 or older
- People who are awake and conscious
- People who speak and understand Turkish
- People who have been diagnosed with breast cancer
- People who are scheduled to receive a chemotherapy medicine called paclitaxel
- People who answered "no" to a specific section of a symptom questionnaire called the CIPNAT scale (confirm with trial site for details on this assessment)
Who may not be able to join:
- People whose vibration sensation test suggests nerve damage may already be present (this is checked by a practitioner using a small vibrating tool)
- People who cannot feel pressure in two or more of three specific areas on the sole of the foot, based on a touch sensitivity test using a thin filament
- People who have previously experienced nerve damage related to chemotherapy
- People who have been diagnosed with diabetes
- People who have open wounds or skin ulcers on their feet
- People who have a disease affecting the peripheral or central nervous system
- People who have peripheral vascular disease (a condition affecting blood flow in the blood vessels outside the heart)
- People who have cancer that has spread to the bones or soft tissue
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +905059683332
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To prevent the development of chemotherapy-associated peripheral neuropathy in patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.